Core indicators of an evaluation and guidance system for quality of care in inflammatory bowel disease centers: A critical review
- PMID: 35434585
- PMCID: PMC9011022
- DOI: 10.1016/j.eclinm.2022.101382
Core indicators of an evaluation and guidance system for quality of care in inflammatory bowel disease centers: A critical review
Abstract
The mission of the IBD Quality Care Evaluation Center (IBDQCC) is to establish indicators of quality of care (QoC), certify IBD units to generate a network of IBD quality care, and eventually improve the national level of IBD healthcare. The final list of 28 core and 13 secondary IBD QoC indicators suitable for the healthcare system in China were selected using a Delphi consensus methodology. Units that met all core indicators were qualified as "regional"; units that met all core indicators together with more than 50% of the secondary indicators received a rating of "excellence." Using the selected QoC core indicators for certifying IBD units, a network of IBD quality care units covering the majority of IBD patients in China was established.
Funding: This work was financially supported by Cultivation Funding for Clinical Scientific Research Innovation, Renji Hospital, School of Medicine, Shanghai Jiaotong University (RJPY-LX-004), National Natural Science Foundation of China (No. 81,770,545), Shanghai Science and Technology Innovation Initiative (21SQBS02302), and Cultivated Funding for Clinical Research Innovation, Renji Hospital, School of Medicine, Shanghai Jiaotong University (RJPY-LX-004).
Keywords: Core indicators; Inflammatory bowel disease; Inflammatory bowel disease quality care evaluation center; Quality of care.
© 2022 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Secondary Indicators for an Evaluation and Guidance System for Quality of Care in Inflammatory Bowel Disease Centers: A Critical Review of the Inflammatory Bowel Disease Quality of Care Center.Inflamm Bowel Dis. 2022 Jun 2;28(Suppl 2):S3-S8. doi: 10.1093/ibd/izac009. Inflamm Bowel Dis. 2022. PMID: 35247049 Review.
-
Improving Quality of Care in Inflammatory Bowel Disease Through Patients' Eyes: IQCARO Project.Inflamm Bowel Dis. 2020 Apr 11;26(5):782-791. doi: 10.1093/ibd/izz126. Inflamm Bowel Dis. 2020. PMID: 31634907 Review.
-
Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience.United European Gastroenterol J. 2021 Sep;9(7):766-772. doi: 10.1002/ueg2.12105. Epub 2021 Jun 5. United European Gastroenterol J. 2021. PMID: 34089303 Free PMC article.
-
Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU.Rev Gastroenterol Mex (Engl Ed). 2022 Jan-Mar;87(1):89-102. doi: 10.1016/j.rgmxen.2021.05.013. Epub 2021 Dec 3. Rev Gastroenterol Mex (Engl Ed). 2022. PMID: 34866040
-
Delphi consensus statement: Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units.J Crohns Colitis. 2014 Mar;8(3):240-51. doi: 10.1016/j.crohns.2013.10.010. Epub 2013 Dec 2. J Crohns Colitis. 2014. PMID: 24295646
Cited by
-
Person-Centered Coordinated Care Experience of People With Long-Term Conditions in the Balearic Islands Measured by the P3CEQ.Health Serv Insights. 2024 Jun 13;17:11786329241258856. doi: 10.1177/11786329241258856. eCollection 2024. Health Serv Insights. 2024. PMID: 38883804 Free PMC article.
-
An Immersive Human-Robot Interactive Game Framework Based on Deep Learning for Children's Concentration Training.Healthcare (Basel). 2022 Sep 15;10(9):1779. doi: 10.3390/healthcare10091779. Healthcare (Basel). 2022. PMID: 36141391 Free PMC article.
-
Should Inflammatory Bowel Disease Clinicians Provide Their Patients with e-Health Resources? Patients' and Professionals' Perspectives.Telemed J E Health. 2023 Oct;29(10):1504-1513. doi: 10.1089/tmj.2022.0425. Epub 2022 Dec 22. Telemed J E Health. 2023. PMID: 36576850 Free PMC article.
-
Effect of mesalazine combined with probiotics on inflammation and immune function of patients with inflammatory bowel disease.Am J Transl Res. 2022 Nov 15;14(11):8234-8242. eCollection 2022. Am J Transl Res. 2022. PMID: 36505287 Free PMC article.
References
-
- Melmed G.Y., Siegel C.A., Spiegel B.M., et al. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis. 2013;19(3):662–668. - PubMed
-
- Disease CSoIB Consensus on quality of control index for diagnosis and treatment in inflammatory bowel disease centers in China[J] Chin J Intern Med. 2016;55(7):568–571. - PubMed
-
- Disease CSoIB Consensus on key quality of control indicators for diagnosis and treatment of inflammatory bowel disease in China[J] Chin J Inflamm Bowel Dis. 2017;1(1):12–19.
-
- Calvet X., Panes J., Alfaro N., et al. Delphi consensus statement: quality indicators for inflammatory bowel disease comprehensive care units. J Crohns Colitis. 2014;8(3):240–251. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous